Search Constraints
Filtering by:
Funding statement
Funding for this research was provided by U54 HD071600-0109/26/2011-06/30/2016 NICHD on Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy (to G.S. and V.N.).
G.S. has received speaking honoraria from Cubist, Forest, and Novartis Pharmaceuticals, consulting fees from Cubist and Forest Pharmaceuticals, and research grant support from Forest Pharmaceuticals. M.J.R. has received speaking honoraria from Cubist, Forest, Novartis, and Sunovion, consulting fees from Durata, Cubist, Forest, Cepheid, and Theravance, and research grant support from Cubist, Forest, and Cerexa Pharmaceuticals.
Remove constraint Funding statement: Funding for this research was provided by U54 HD071600-0109/26/2011-06/30/2016 NICHD on Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy (to G.S. and V.N.).
G.S. has received speaking honoraria from Cubist, Forest, and Novartis Pharmaceuticals, consulting fees from Cubist and Forest Pharmaceuticals, and research grant support from Forest Pharmaceuticals. M.J.R. has received speaking honoraria from Cubist, Forest, Novartis, and Sunovion, consulting fees from Durata, Cubist, Forest, Cepheid, and Theravance, and research grant support from Cubist, Forest, and Cerexa Pharmaceuticals.